New model predicts that prevalence of obesity among Australian adults may significantly increase by 2025

New modelling predicts the prevalence of obesity and severe obesity among Australian adults will significantly increase by 2025, as part of a wider research project examining the most effective ways to combat obesity. New model predicts that prevalence of obesity among Australian adults may significantly increase by 2025

Review highlights potentially toxic effects of herbal and dietary supplements on the liver

A new review based on a research symposium sponsored by the American Association for the Study of Liver Disease and the National Institutes of Health highlights the potentially damaging effects of herbal and dietary supplements (HDSs) on the liver. Review highlights potentially toxic effects of herbal and dietary supplements on the liver

New study looks at better ways to treat obesity in rural areas

Currently, excess body weight contributes to as many as 1 in 5 cancer-related deaths. Obesity is associated with increased risk of at least eight types of cancer. New study looks at better ways to treat obesity in rural areas

New ABT approach results in greater weight loss than gold standard treatment, study shows

A new approach to weight loss called Acceptance-Based Behavioral Treatment (ABT) helped people lose more weight and keep it off longer than those who received only Standard Behavioral Treatment (SBT) - a typical treatment plan encouraging reduced caloric intake and increased physical activity - according to a new randomized controlled clinical trial. New ABT approach results in greater weight loss than gold standard treatment, study shows

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis announced today that the US Food and Drug Administration has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes. Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Researchers report safety of laparoscopic sleeve gastrectomy from nationwide bariatric registry

By analyzing information included in the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database, the largest bariatric-specific nationwide registry, researchers found that laparoscopic sleeve gastrectomy is a safe procedure with a low morbidity rate. Researchers report safety of laparoscopic sleeve gastrectomy from nationwide bariatric registry

Groundbreaking research findings could lead to potential new treatments for Crohn’s disease

A Case Western Reserve University School of Medicine-led team of international researchers has for the first time identified a fungus as a key factor in the development of Crohn's disease. Groundbreaking research findings could lead to potential new treatments for Crohn’s disease

Food intolerance testing: an interview with Dr Gill Hart

Food intolerances are caused by adverse reactions to food or drink ingredients in your body. These are very different to food allergies. It is estimated that up to forty-five percent of the population suffers from food intolerances. Food intolerance testing: an interview with Dr Gill Hart

Study provides insight into how weight-loss drug acts in the brain

A weight-loss drug dampened the response to food cues in regions of the brain associated with attention and emotion, leading to decreases in caloric intake, weight and body mass index (BMI), a team led by scientists at Beth Israel Deaconess Medical Center reported. Study provides insight into how weight-loss drug acts in the brain